TRANSCEND FL: Phase II study results of lisocabtagene maraleucel (liso-cel) in patients with R/R follicular lymphoma (FL) Meeting Abstract


Authors: Nastoupil, L. J.; Dahiya, S.; Palomba, M. L.; Garcia-Sancho, A. M.; Ortega, J. L. R.; Kuruvilla, J.; Jager, U.; Cartron, G.; Izutsu, K. I.; Dreyling, M.; Kahl, B.; Ghesquieres, H.; Ardeshna, K.; Goto, H.; Barbui, A. M.; Abramson, J. S.; Borchmann, P.; Fleury, I.; Mielke, S.; Farazi, T.; Fasan, O.; Lymp, J.; Vedal, M.; Nishii, R.; Avilion, A.; Papuga, J.; Morschhauser, F.
Abstract Title: TRANSCEND FL: Phase II study results of lisocabtagene maraleucel (liso-cel) in patients with R/R follicular lymphoma (FL)
Meeting Title: 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy
Keywords: phase ii; follicular lymphoma; relapsed or refractory; ibcl; liso-cel; indolent nhl; third line or later
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 23
Issue: Suppl. 1
Meeting Dates: 2023 Sep 6-9
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2023-09-01
Start Page: S447
End Page: S448
Language: English
ACCESSION: WOS:001062479600482
PROVIDER: wos
DOI: 10.1016/S2152-2650(23)01349-6
Notes: Meeting Abstract: IBCL-098 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    417 Palomba